This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Nerviano Medical Services S.r.l.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Bernard Laffranchi: Innovator in Cancer Treatment
Introduction
Bernard Laffranchi is a notable inventor based in Bubbiano, Italy. He has made significant contributions to the field of cancer treatment, particularly through his innovative patent related to thymoma.
Latest Patents
Laffranchi holds a patent for the "Use of kinase inhibitor for the treatment of thymoma." This invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor for use in the treatment of thymoma and thymic carcinoma. The compound can be administered alongside one or more cytotoxic or cytostatic agents, showcasing its potential in enhancing cancer therapies.
Career Highlights
Throughout his career, Bernard Laffranchi has worked with prominent companies in the pharmaceutical sector, including Nerviano Medical Services S.r.l. and Nerviano Medical Sciences S.r.l. His work has focused on developing innovative solutions for complex medical challenges.
Collaborations
Laffranchi has collaborated with several professionals in his field, including Angela Scaburri and Maria Adele Pacciarini. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Bernard Laffranchi's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to influence the field of oncology and highlights the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile